Live Quiz Arena
🎁 1 Free Round Daily
⚡ Enter ArenaQuestion
← Human Body & HealthIf a patient has a genetic defect causing decreased fibrinogen production, why does platelet aggregation become impaired?
A)Reduced calcium signaling occurs
B)Thromboxane A2 production increases excessively
C)Fibrin bridges cannot form properly✓
D)Von Willebrand factor is degraded rapidly
💡 Explanation
Platelet aggregation depends on fibrinogen binding to platelet receptors to form fibrin bridges between platelets. Reduced fibrinogen impairs this mechanism, because platelets cannot effectively cross-link to create a stable plug. Therefore, aggregation is impaired, rather than proceeding normally or being related to calcium or vWF.
🏆 Up to £1,000 monthly prize pool
Ready for the live challenge? Join the next global round now.
*Terms apply. Skill-based competition.
Related Questions
Browse Human Body & Health →- Why does elevated inhibin B during ovarian stimulation protocols sometimes prevent successful oocyte retrieval?
- A woman experiences premature luteolysis after IVF; which consequence follows regarding implantation?
- If a novel influenza strain evades antibody neutralization, which consequence follows regarding CD8+ T-cell mediated immunity?
- Why does heart failure become likely in individuals with untreated beriberi?
- If a football player experiences a rotational head impact, which cascade explains why diffuse axonal injury occurs, exceeding cellular strain tolerance?
- Why does wearing tight gloves in cold weather increase the risk of frostbite in the fingers, compared to wearing looser fitting gloves?
